Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles
Chino D Cambridge, Shree R Singh, Alain B Waffo, Stacie J Fairley, Vida A DennisCenter for NanoBiotechnology Research (CNBR), Alabama State University, Montgomery, AL, USAAbstract: Chlamydia trachomatis is a bacterial sexually transmitted infection affecting millions of people worldwide. Previous va...
Guardado en:
Autores principales: | Cambridge CD, Singh SR, Waffo AB, Fairley SJ, Dennis VA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/154dd463a50948db8970a170ac993f90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
por: Fairley SJ, et al.
Publicado: (2013) -
A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars
por: Anja Weinreich Olsen, et al.
Publicado: (2021) -
Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis
por: Yilma AN, et al.
Publicado: (2013) -
A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system
por: Eroglu E, et al.
Publicado: (2013) -
THE PREVALENCE OF CHLAMYDIA TRACHOMATIS INFECTION IN SAINT-PETERSBURG
por: L. B. Kulyashova, et al.
Publicado: (2014)